Avanos Medical (AVNS) Operating Margin (2013 - 2026)
Avanos Medical (AVNS) reported Operating Margin of 4.88% for Q1 2026, down 126.0% on a YoY basis from 18.79% in Q1 2025, and up 253.46% sequentially from 1.38% in Q4 2025.
Avanos Medical (AVNS) Operating Margin (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Operating Margin data on file, last reported at 4.88% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 126.0% year-over-year to 4.88%; the trailing twelve-month figure through Mar 2026 stood at 8.8% (up 4777.0% YoY), and the FY2025 full-year result was 8.78%, up 4882.0% from the prior year.
- Operating Margin grew to 4.88% in Q1 2026, from 1.38% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 9.14% in Q4 2022 to a low of 233.02% in Q4 2024.
- A 5-year average of 13.0% and a median of 3.67% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin sank 23948 bps in 2024 and jumped 23440 bps in 2025, its largest moves.
- Tracing AVNS's Operating Margin over 5 years: stood at 9.14% in 2022, then slipped by 29 bps to 6.46% in 2023, then plunged by 3706 bps to 233.02% in 2024, then surged by 101 bps to 1.38% in 2025, then jumped by 253 bps to 4.88% in 2026.
- Business Quant data shows AVNS's Operating Margin at 4.88% in Q1 2026, 1.38% in Q4 2025, and 0.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | 4.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.88% |
| Dec 31, 2025 | 1.38% |
| Sep 30, 2025 | 0.06% |
| Jun 30, 2025 | -42.57% |
| Mar 31, 2025 | 6.15% |
| Dec 31, 2024 | -233.02% |
| Sep 30, 2024 | 7.04% |
| Jun 30, 2024 | 3.67% |
| Mar 31, 2024 | 2.41% |
| Dec 31, 2023 | 6.46% |
| Sep 30, 2023 | 0.70% |
| Jun 30, 2023 | -1.24% |
| Mar 31, 2023 | -3.83% |
| Dec 31, 2022 | 9.14% |
| Sep 30, 2022 | 7.43% |
| Jun 30, 2022 | 5.91% |
| Mar 31, 2022 | 4.36% |
| Dec 31, 2021 | -62.57% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | -3.92% |